Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study

BACKGROUND: Wearable cardioverter defibrillator (WCD) therapy is feasible and safe in patients as a transient protection against sudden cardiac death (SCD). However, the impact of WCD therapy on quality of life (QoL) has not been studied. METHODS: In our single-centre study, 109 consecutive patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lackermair, Korbinian, Schuhmann, Christoph G., Kubieniec, Michaela, Riesinger, Lisa M., Klier, Ina, Stocker, Thomas J., Kääb, Stefan, Estner, Heidi L., Fichtner, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040298/
https://www.ncbi.nlm.nih.gov/pubmed/30050939
http://dx.doi.org/10.1155/2018/6028494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040298/
https://www.ncbi.nlm.nih.gov/pubmed/30050939
http://dx.doi.org/10.1155/2018/6028494

Ejemplares similares